Zorabi-CP
Description_Effects
Zorabi-CP is a combination medicine containing Rabeprazole Sodium and Cinitapride, formulated to provide effective relief from acid-related gastrointestinal disorders. Rabeprazole is a proton pump inhibitor (PPI) that works by reducing the amount of acid produced in the stomach. It is commonly used to treat conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. By decreasing stomach acid, it helps relieve symptoms like heartburn, acid reflux, and indigestion while promoting ulcer healing. Cinitapride, on the other hand, is a prokinetic agent that enhances gastrointestinal motility. It increases the movement of the stomach and intestines, helping food move more efficiently through the digestive tract. This action makes it particularly helpful in treating functional dyspepsia, bloating, nausea, and delayed gastric emptying. Together, these two ingredients offer dual-action relief by targeting both acid suppression and digestive tract movement. Zorabi-CP is usually taken before meals and should be used under medical supervision. Regular use as prescribed can significantly improve symptoms, enhance digestive comfort, and support overall gastrointestinal health. It is important to follow your doctor’s instructions and complete the full course of treatment for the best results.
